ArticleNature communications2025

Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment.

Vanessa Neiens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.